AVAILABILITY OF GLIVEC

Early day motion 348, tabled 8 December 2004 by Mike Hancock (Liberal Democrat). Signed by 23 members.

That this House supports the guidance issued by the Department of Health ensuring that Glivec, a novel treatment for chronic myeloid leukaemia, is available on the NHS; and welcomes the recognition that has now been granted by the National Institute for Clinical Excellence, without restrictions, which ensures another step forward in the constant battle against this terrible disease.

Signatures by party: Labour 12, Liberal Democrat 8, UUP 2, Labour/Co-operative 1.